Preferred Label : Stage II Prostate Adenocarcinoma AJCC v7;
NCIt related terms : Stage II Prostate Adenocarcinoma;
NCIt definition : Stage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0,
PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0,
M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20,
Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0,
Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2,
N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histologic finding
in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more
than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because
of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves
more than one-half of one lobe, but not both lobes. T2c: Tumor involves both lobes.
cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant
metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal
or Less than 6: Well differentiated (slight anaplasia). Gleason equal or more than
8: Poorly differentiated/undifferentiated (marked anaplasia). (AJCC 7th ed.);
Neoplastic status : Malignant;
Origin ID : C8948;
UMLS CUI : C0862641;
Currated CISMeF NLP mapping
- Disease excludes abnormal cell
- Disease may have findings
- Has associated anatomic sites
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
- disease_mapped_to_gene
- disease_may_have_molecular_abnormality
